Guideline for PET/CT imaging of neuroendocrine neoplasms with68Ga-DOTA-conjugated somatostatin receptor targeting peptides and18F-DOPA.
MetadataShow full item record
PURPOSE & METHODS: Neuroendocrine neoplasms are a heterogenous group of tumours, for which nuclear medicine plays an important role in the diagnostic work-up as well as in the targeted therapeutic options. This guideline is aimed to assist nuclear medicine physicians in recommending, performing, reporting and interpreting the results of somatostatin receptor (SSTR) PET/CT imaging using68Ga-DOTA-conjugated peptides, as well as18F-DOPA imaging for various neuroendocrine neoplasms. RESULTS & CONCLUSION: The previous procedural guideline by EANM regarding the use PET/CT tumour imaging with68Ga-conjugated peptides has been revised and updated with the relevant and recent literature in the field with contribution of distinguished experts.
Version of record
Hyperinsulism in infants
Thyroid medullary cancer
Translational Molecular Imaging
License start date
Eur J Nucl Med Mol Imaging, 2017, 44 (9), pp. 1588 - 1601